α(v)β(6)-Targeted Molecular PET/CT Imaging of the Lungs After SARS-CoV-2 Infection

The true impact and long-term damage to organs such as the lungs after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain to be determined. Noninvasive molecularly targeted imaging may play a critical role in aiding visualization and understanding of the systemic damage. We have identified α(v)β(6) as a molecular target; an epithelium-specific cell surface receptor that is low or undetectable in healthy adult epithelium but upregulated in select injured tissues, including fibrotic lung. Herein we report the first human PET/CT images using the integrin α(v)β(6)-binding peptide ((18)F-α(v)β(6)-BP) in a patient 2 mo after the acute phase of infection. Minimal uptake of (18)F-α(v)β(6)-BP was noted in normal lung parenchyma, with uptake being elevated in areas corresponding to opacities on CT. This case suggests that (18)F-α(v)β(6)-BP PET/CT is a promising noninvasive approach to identify the presence and potentially monitor the persistence and progression of lung damage.